Dermatomyositis–lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis
Main Authors: | Anna Lyakhovitsky, MD, Karin Warshavsky, MD, Lihi Rozner, MD, Theodoulos Drousiotis, MD, Sharon Baum, MD, Aviv Barzilai, MSc, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512620304367 |
Similar Items
-
A novel overlap syndrome: Rheumatoid arthritis, Sjogren's syndrome, antiphospholipid syndrome, and dermatomyositis
by: Maab Jasim Mohammed, et al.
Published: (2023-04-01) -
Overlap syndrome of type Wong variant dermatomyositis and rheumatoid arthritis
by: Yen-Jen Wang, et al.
Published: (2014-03-01) -
Erythroderma as a presenting sign of juvenile overlap syndrome
by: Sarah Hamdy Soliman, et al.
Published: (2023-01-01) -
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
by: Rachel Choi, MD, et al.
Published: (2022-11-01) -
Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017-01-01)